Decision and Details
Board of directors of 株式会社ASNOVA (formal decision on the new program: board of directors of 株式会社ASNOVA Companies)Ending the current shareholder benefit program and introducing a new shareholder benefit program at the holding company
To prioritize the allocation of limited management resources to growth investments, including M&A, human capital and the strengthening of the business platform. Through dialogue with shareholders, the company received substantial feedback calling for benefits that convey not only the amount of the return but also what makes ASNOVA distinctive and the significance of being a shareholder.
The program is expected to contribute positively to earnings through the appropriate optimization of shareholder benefit costs. The contribution is expected to begin in the fiscal year ending March 2028, while the impact on the consolidated earnings forecast for the fiscal year ending March 2027 is expected to be minor.
| Item | Details |
|---|---|
| Matter Covered | Ending the current shareholder benefit program and introducing a new shareholder benefit program at the holding company |
| Decision-Making Body | Board of directors of 株式会社ASNOVA (formal decision on the new program: board of directors of 株式会社ASNOVA Companies) |
| Decision Date | 14 September 2026 |
| Implementation Date | The current program will end with the benefit granted based on 30 September 2026 as the record date (decided). The proposed new program is scheduled to use 31 March 2027 as its first record date (pending formal approval). |
| Period Covered | The current program will use 30 September 2026 as its final record date. The proposed new program will use 31 March 2027 as its first record date and 31 March of each subsequent year. |
| Amount | Current program: 5,000–13,000 points depending on the number of shares held for holdings of 500 or more but fewer than 1,000 shares, and 15,000 points for holdings of 1,000 or more shares. Proposed new program: products worth ¥5,000 for holdings of 1,000–4,999 shares, and products worth ¥10,000 for holdings of 5,000 or more shares. |
| Quantity / scale | The current program is offered twice a year and covers shareholders holding 500 or more shares (5 units). The proposed new program will be offered once a year and cover shareholders who have continuously held 1,000 or more shares (10 units) for at least one year. As a transitional measure for the first record date, shareholders who hold 500 or more shares as of 30 September 2026 and 1,000 or more shares as of 31 March 2027 are scheduled to be eligible. |
| Impact on Business Performance | The program is expected to contribute positively to earnings through the appropriate optimization of shareholder benefit costs. The contribution is expected to begin in the fiscal year ending March 2028, while the impact on the consolidated earnings forecast for the fiscal year ending March 2027 is expected to be minor. |
| Reason | To prioritize the allocation of limited management resources to growth investments, including M&A, human capital and the strengthening of the business platform. Through dialogue with shareholders, the company received substantial feedback calling for benefits that convey not only the amount of the return but also what makes ASNOVA distinctive and the significance of being a shareholder. |
| Future plans | The holding company is scheduled to be established on 1 October 2026. The new program is scheduled to be formally decided by the holding company’s board of directors in October 2026. The deadline for exchanging points under the current program is 28 February 2027. The proposed new program’s first record date is 31 March 2027, and the notice regarding the first shareholder benefit is scheduled to be sent around June 2027. |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To prioritize the allocation of limited management resources to growth investments that will lead to higher corporate value, including M&A, human capital and the strengthening of the business platform. The program is also being reviewed in response to feedback received through dialogue with shareholders calling for benefits that convey not only the amount of the return but also what makes ASNOVA distinctive and the significance of being a shareholder.